#
Tomocat
  • Professionals
  • FDA PI

Tomocat

Generic name:barium sulfate
Dosage form: oral and rectal suspension
Drug class:Non-iodinated contrast media

Medically reviewed by Drugs.com. Last updated on Jul 22, 2021.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Tomocat Description

Tomocat is a strawberry flavored barium sulfate suspension concentrate for dilution and oral or rectal/colon administration as an aid for computed tomography of the gastrointestinal tract.

Tomocat contains approximately 5% w/v barium sulfate USP, suspending agents, sorbitol, citric acid, simethicone, flavoring, potassium sorbate, saccharin sodium and water. Barium sulfate has the empirical formula of BaSO4.

Tomocat - Clinical Pharmacology

Barium sulfate is an insoluble material which, because of its density, provides a positive contrast during x-ray examination. Barium sulfate is an inert radiopaque material which is not absorbed or metabolized and is eliminated intact from the body in a manner similar to other non-absorbed inorganic materials. Excretion rate is a function of gastrointestinal transit time.

Indications and Usage for Tomocat

Tomocat is indicated for use as a diagnostic aid (contrast medium) for computed tomography of the gastrointestinal tract.

Contraindications

Barium sulfate products are contraindicated in patients with known or suspected obstruction of the colon, known or suspected gastrointestinal tract perforation, suspected tracheoesophageal fistula, obstructing lesions of the small intestine, pyloric stenosis, inflammation or neoplastic lesions of the rectum, recent rectal biopsy or known hypersensitivity to barium sulfate formulations.

Barium sulfate suspensions should not be used for infants with swallowing disorders or for newborns with complete duodenal or jejunal obstruction or when distal small bowel or colon obstruction is suspected. Barium sulfate suspension is not recommended for very small preterm infants and young babies requiring small volumes of contrast media or for infants and young children when there is a possibility of leakage from the gastrointestinal tract, such